Trial
NCT00023504
Antibody Production in Immune Disorders
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
—
Condition
Primary Immune Deficiency
Intervention
Pneumovax
Why stopped
Slow/Insufficient accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-15